Neurocore Aims To Treat Clinical Depression and ADHD Using Neurotherapy

Founded in 2004, Neurocore became in quick fashion an authority in regards to applied neuroscience, applying the knowledge of EEG technology, neurofeedback and brain mapping in order to improve mental acuity of their patients and treat disorders such as anxiety, depression, ASD and ADHD. Despite the rich history of neurotherapeutic application, they have only recently started to be available to the public at large.

Clinical depression is a major disorder which, according to a study conducted by the National Institute of Mental Health in 2016, affects 10 million adults in the US. The causes are not fully known, but many factors are to be taken into consideration, such as genetics, hormone and brain chemistry. The traditional treatments include psychotherapy and antidepressants.

Neurocore, using the information and research about neurotherapy, are currently offering a Medication-Free Depression Treatment Program. The program uses neurofeedback in order to train the patient’s brain in order to overcome the severity that the symptoms of depression have, and in some cases to overcome the disorder completely. The therapy they offer starts with a brain assessment, which is done by using the qEEG brainwave mapping technology. 292 clients completed the 30-session program that Neurocore offers, and 84% experienced a reduction of their depressive symptoms, while 51% did not meet the symptomatic threshold of depression anymore.

Another major disorder that Neurocore aims to treat using neurotherapy is ADHD. A common disorder for children, but one that can last until adulthood. ADHD can be Predominantly Hyperactive-Impulse Presentation, Predominantly Inattentive Presentation, or a combination of the two. It usually manifests through hyperactivity, inattentiveness and impulsiveness. The effects of neurofeedback on the ADHD disorder have been documented ever since 1976, when J.F. Lubar managed to improve a child’s hyperactivity and distractibility.

Out of thousands of children that suffer from ADHD and used Neurocore’s program, 85% of them noticed a reduction of the symptoms, and 53% of them are no longer meeting the symptomatic threshold of the disorder. ADHD can be linked to poor sleep quality, anxiety, and a learning disability, among others. As a result Neurocore focuses on finding the root of the attention problems by using qEEG technology